Request for Covid-19 Impact Assessment of this Report
The United States Irritable Bowel Syndrome (IBS) Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Irritable Bowel Syndrome (IBS) Diagnostics market, reaching US$ million by the year 2028. As for the Europe Irritable Bowel Syndrome (IBS) Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Irritable Bowel Syndrome (IBS) Diagnostics players cover Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, and Prometheus Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Laboratory Tests
Imaging Tests
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and Clinics
Diagnostic Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
Buhlmann Laboratories AG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2017-2028
2.1.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Type
2.2.1 Laboratory Tests
2.2.2 Imaging Tests
2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type
2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Others
2.5 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application
2.5.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
3 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Player
3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) Diagnostics by Regions
4.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2017-2022)
4.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2017-2022)
4.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022)
5.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022)
5.3 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2017-2022)
6.2 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022)
6.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics by Country (2017-2022)
7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022)
7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.2.2 Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.2.3 Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.2.4 Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2023-2028)
10.3.1 China Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.2 Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.3 Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.4 Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.5 India Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.6 Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.4.2 France Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.4.3 UK Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.4.4 Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.4.5 Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.5.2 South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.5.3 Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.5.4 Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.5.5 GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Type (2023-2028)
10.7 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Commonwealth Diagnostics International
11.1.1 Commonwealth Diagnostics International Company Information
11.1.2 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Commonwealth Diagnostics International Main Business Overview
11.1.5 Commonwealth Diagnostics International Latest Developments
11.2 Genova Diagnostics
11.2.1 Genova Diagnostics Company Information
11.2.2 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Genova Diagnostics Main Business Overview
11.2.5 Genova Diagnostics Latest Developments
11.3 Gemelli Biotech
11.3.1 Gemelli Biotech Company Information
11.3.2 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gemelli Biotech Main Business Overview
11.3.5 Gemelli Biotech Latest Developments
11.4 Prometheus Laboratories
11.4.1 Prometheus Laboratories Company Information
11.4.2 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Prometheus Laboratories Main Business Overview
11.4.5 Prometheus Laboratories Latest Developments
11.5 Inova Diagnostics, Inc.
11.5.1 Inova Diagnostics, Inc. Company Information
11.5.2 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Inova Diagnostics, Inc. Main Business Overview
11.5.5 Inova Diagnostics, Inc. Latest Developments
11.6 Biohit Oyj
11.6.1 Biohit Oyj Company Information
11.6.2 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Biohit Oyj Main Business Overview
11.6.5 Biohit Oyj Latest Developments
11.7 Aerodiagnostics, LLC.
11.7.1 Aerodiagnostics, LLC. Company Information
11.7.2 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Aerodiagnostics, LLC. Main Business Overview
11.7.5 Aerodiagnostics, LLC. Latest Developments
11.8 Metabolic Solutions, Inc.
11.8.1 Metabolic Solutions, Inc. Company Information
11.8.2 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Metabolic Solutions, Inc. Main Business Overview
11.8.5 Metabolic Solutions, Inc. Latest Developments
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Information
11.9.2 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sysmex Corporation Main Business Overview
11.9.5 Sysmex Corporation Latest Developments
11.10 Buhlmann Laboratories AG
11.10.1 Buhlmann Laboratories AG Company Information
11.10.2 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Buhlmann Laboratories AG Main Business Overview
11.10.5 Buhlmann Laboratories AG Latest Developments
12 Research Findings and Conclusion
Table 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Laboratory Tests
Table 3. Major Players of Imaging Tests
Table 4. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
Table 13. Irritable Bowel Syndrome (IBS) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome (IBS) Diagnostics
Table 43. Key Market Challenges & Risks of Irritable Bowel Syndrome (IBS) Diagnostics
Table 44. Key Industry Trends of Irritable Bowel Syndrome (IBS) Diagnostics
Table 45. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Commonwealth Diagnostics International Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 52. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 53. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Commonwealth Diagnostics International Main Business
Table 55. Commonwealth Diagnostics International Latest Developments
Table 56. Genova Diagnostics Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 57. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 58. Genova Diagnostics Main Business
Table 59. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Genova Diagnostics Latest Developments
Table 61. Gemelli Biotech Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 62. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 63. Gemelli Biotech Main Business
Table 64. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Gemelli Biotech Latest Developments
Table 66. Prometheus Laboratories Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 67. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 68. Prometheus Laboratories Main Business
Table 69. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Prometheus Laboratories Latest Developments
Table 71. Inova Diagnostics, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 72. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 73. Inova Diagnostics, Inc. Main Business
Table 74. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Inova Diagnostics, Inc. Latest Developments
Table 76. Biohit Oyj Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 77. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 78. Biohit Oyj Main Business
Table 79. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Biohit Oyj Latest Developments
Table 81. Aerodiagnostics, LLC. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 82. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 83. Aerodiagnostics, LLC. Main Business
Table 84. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Aerodiagnostics, LLC. Latest Developments
Table 86. Metabolic Solutions, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 87. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 88. Metabolic Solutions, Inc. Main Business
Table 89. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Metabolic Solutions, Inc. Latest Developments
Table 91. Sysmex Corporation Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 92. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 93. Sysmex Corporation Main Business
Table 94. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sysmex Corporation Latest Developments
Table 96. Buhlmann Laboratories AG Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 97. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 98. Buhlmann Laboratories AG Main Business
Table 99. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Buhlmann Laboratories AG Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type in 2021
Figure 7. Irritable Bowel Syndrome (IBS) Diagnostics in Hospitals and Clinics
Figure 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Hospitals and Clinics (2017-2022) & ($ Millions)
Figure 9. Irritable Bowel Syndrome (IBS) Diagnostics in Diagnostic Centers
Figure 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Diagnostic Centers (2017-2022) & ($ Millions)
Figure 11. Irritable Bowel Syndrome (IBS) Diagnostics in Others
Figure 12. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2021
Figure 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player in 2021
Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Irritable Bowel Syndrome (IBS) Diagnostics Value Market Share by Country in 2021
Figure 21. Americas Irritable Bowel Syndrome (IBS) Diagnostics Consumption Market Share by Type in 2021
Figure 22. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2021
Figure 23. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region in 2021
Figure 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2021
Figure 29. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country in 2021
Figure 36. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type in 2021
Figure 37. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2021
Figure 38. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2021
Figure 46. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...